Arthritis Care and Research… Winter 2026 Press Review – Arthritis Care and Research 18 Jan 2026 August 2025 to November 2025 Author: Victoria Sadovici-Bobeica 2024 American College of Rheumatology (ACR) Guideline for the Screening, Treatment, and Management of Lupus Nephritis Sammaritano LR et al. (10.1002/art.43212) in this…
Arthritis and Rheumatology… Winter 2026 Press Review – Arthritis & Rheumatology 18 Jan 2026 August 2025 to November 2025 Author: Victoria Sadovici-Bobeica Long-Term Safety and Efficacy of Mepolizumab in Eosinophilic Granulomatosis With Polyangiitis Wechsler ME et al. (10.1002/art.43146) in this open-label extension of the…
Press Review… Winter 2026 Press Review – RMD Open 18 Jan 202618 Jan 2026 August 2025 to November 2025 Author: Giovanni Fulvio ‘Fast Ossifier’ in diffuse idiopathic skeletal hyperostosis: a sex-modulated, heterogeneous phenotype with accelerated ossification and early trabecular decline Pariente-Rodrigo et al. (10.1136/rmdopen-2025-006024) found…
Press Review… Winter 2026 Press Review – The Lancet Rheumatology 18 Jan 2026 August 2025 to November 2025 Author: Nikolaos Vlachogiannis Effectiveness of treat-to-target tapering of TNF inhibitors in spondyloarthritides: a 24-month follow-up study Amy C D Peeters et al. (10.1016/s2665-9913(25)00070-0) examined whether a…
EULAR Rheumatology open… Winter 2026 Press Review – Miscellaneous 18 Jan 202618 Jan 2026 August 2025 to November 2025 Author: Maxime Melchior Effects of Long-Term Ixazomib on Bone Mass in Multiple Myeloma Levring et al. (10.1016/j.bone.2025.117660) investigated the impact of ixazomib (an oral proteasome inhibitor)…
EMEUNET… Stats Made Simple: Interpreting tables, graphs, and figures 18 Jan 202616 Mar 2026 What quickly sets experienced readers apart is how efficiently they can extract key information from figures and tables in a scientific article. Each type of scientific publication follows a relatively…
Obesity… Obesity as a risk factor for rheumatic diseases – epidemiological insights 10 Dec 202511 Dec 2025 Obesity is increasingly recognised as a major modifiable risk factor for the development and progression of several rheumatic diseases, including rheumatoid arthritis (RA), psoriatic arthritis (PsA), osteoarthritis (OA), systemic lupus…
Obesity… Beyond Body Weight: Obesity’s Impact on Therapeutic Response in rheumatic diseases 10 Dec 202511 Dec 2025 Obesity poses a dual challenge in inflammatory arthritis: it increases disease risk and reduces treatment effectiveness. Studies show that obesity is independently linked to higher disease activity and weaker response…
Obesity… Obesity and Osteoporosis 10 Dec 202511 Dec 2025 Introduction Obesity is a well-known major global comorbidity, with a prevalence rising steadily over the last few decades. The most recent global data indicate that in 2021, 2.11 billion adults…
Obesity… Adipose Tissue as an Immunological Organ: Adipokines, Low-Grade Inflammation, and Autoimmunity 10 Dec 202511 Dec 2025 Adipose tissue (AT), once perceived merely as a simple depot for energy storage, has emerged as a complex immunological organ (1). In human, there are 3 types of AT based…